HSPA9 and bacterial infectious disease: These identified interactions largely confirm a number of previous discovered functions such as participation in chaperone activity, control of cell proliferation and cellular aging (grp75), modulation of cellular transformation and participation in haemostasis and thrombosis (fibulin-1), as well as modulation of the complement system in fighting bacterial infection (C1 esterase inhibitor).